如需购买Thermo Fisher Scientific公司伴随诊断产品,请微信扫描下方二维码联系客服
预计2019年全球伴侣诊断市场价值为XX.X亿美元。《伴生诊断市场报告》对截至2029年的预测年度的市场动态、竞争情景、机会分析、市场增长等进行了定性和定量分析。全球伴侣诊断市场根据类型、应用和地理位置进行细分。2019年,北美市场价值为XX.X百万美元,市场份额估计为X.X%,预计2029年为XX.X百万美元和X.X%,2020年至2029年的复合年增长率为X.X%。全球伙伴诊断市场按类型,市场分为聚合酶链反应(PCR)、免疫组织化学(IHC)、原位杂交(ISH)和下一代测序(NGS)。根据应用,市场分为医院、制药公司、实验室等。根据地理位置,对北美、欧洲、亚太、拉丁美洲、中东和非洲的市场进行了分析。报告中介绍的主要参与者包括罗氏控股公司、雅培实验室、赛默飞世尔科技公司、安捷伦科技公司、生命科技公司、通用电气医疗保健公司、Agendia公司、Qiagen公司、Genomic Health公司、Myriad Genetics公司、高级细胞诊断公司、Danaher公司和应用蛋白质组学公司。主要细分市场类型聚合酶链反应免疫组织化学原位杂交下一代测序应用医院制药公司实验室其他报告中包括的主要市场参与者:罗氏制药公司雅培实验室赛默飞世尔科技安捷伦科技生命技术通用电气医疗阿根迪亚凯杰基因组健康巨数遗传公司高级细胞诊断达纳赫应用蛋白质组学获取此报告的原因:从洞察力的角度来看,本研究报告致力于多方面的分析——行业研究(全球行业趋势)和相关的诊断市场份额分析,以及公司概况,其中包括关于市场前景、新兴市场和高增长的基本观点配套诊断市场的部分;高增长地区;市场驱动因素、制约因素和市场机会。分析涵盖了伴随诊断市场及其在不同行业垂直领域和地区的发展。它的目标是估计全球伴生诊断市场的当前市场规模和增长潜力,包括应用和代表。此外,该分析还全面回顾了相关诊断市场上的关键参与者,包括他们的公司简介、SWOT分析、最新进展和商业计划。本报告的分析目标是:公平地分享有关影响行业增长的关键因素(增长能力、机会、驱动因素以及行业特定挑战和风险)的深入信息。通过精确定位其许多细分市场来了解配套诊断市场。分析重要的参与者并分析他们的发展计划。根据关键区域(各种重要状态),努力开发配套诊断子市场的数量和价值。分析相关诊断市场的增长趋势、前景以及他们在整个行业中的参与度。调查研究公司配套诊断市场规模(量值)、主要地区/国家、产品和应用、2013年至2018年的背景信息以及2029年的预测。主要全球配套诊断市场制造公司,明确并分析产品销售金额、价值和市场份额、市场竞争格局、SWOT分析和未来几年的发展计划。审查竞争进展,如扩张、安排、新产品发布和市场收购。在配套诊断市场研究研究中,考虑了以下年份来估计市场规模:分光镜地区北美欧洲亚太地区拉丁美洲中东和非洲历史年份2013年至2018年预计2019年预测2020年至2029年配套诊断市场添加购物购物购物车立即获取应用下载示例键盘上箭头关于我的叙述报告代码57777单用户$3495.00多用户$5100.00公司用户$7200.00立即购买1伴随诊断市场介绍1.1条。定义1.2条。分类学1.3条。研究范围2执行摘要2.1条。主要部门的主要发现2.2条。主要参与者的主要策略三。全球伴侣诊断市场概述3.1条。伴随诊断市场动态3.1.1条。司机3.1.2条。机会3.1.3条。约束3.1.4条。挑战3.2条。杵分析3.3条。机会图分析3.4条。波特五力分析3.5条。市场竞争情景分析3.6条。产品生命周期分析3.7条。机会轨道3.8条。按地区/公司划分的生产分析3.9条。产业链分析3.10条。市场营销策略42012-2028年全球伴侣诊断市场价值(单位:百万美元)、份额(%)和增长率(%)比较4.1条。全球伴侣诊断市场分析(按类型):简介4.2条。按地区划分的市场规模和预测4.3。聚合酶链反应4.4条。免疫组织化学4.5条。原位杂交4.6条。下一代测序52012-2028年全球伴侣诊断市场价值(单位:百万美元)、份额(%)和增长率(%)比较5.1条。全球伴侣诊断市场应用分析:简介5.2条。按地区划分的市场规模和预测5.3条。医院5.4条。制药公司5.5条。实验室5.6条。其他62012-2028年,全球伙伴诊断市场价值(单位:百万美元)、份额(%)和增长率(%)比较6.1条。北美6.1.1条。北美同伴诊断市场:区域趋势分析6.1.1.1条。美国6.1.1.2条。加拿大6.1.1.3条。墨西哥6.2.1条。欧洲6.2.1条。欧洲同伴诊断市场:区域趋势分析6.2.1.1条。德国6.2.1.2条。法国6.2.1.3条。英国6.2.1.4条。俄罗斯6.2.1.5条。意大利6.2.1.6条。西班牙6.2.1.7条。欧洲其他地区6.3条。亚太地区6.3.1条。亚太同伴诊断市场:区域趋势分析6.3.1.1条。中国6.3.1.2条。日本6.3.1.3条。韩国6.3.1.4条。印度6.3.1.5条。亚太其他地区6.4条。拉丁美洲6.4.1条。拉美同伴诊断市场:区域趋势分析6.4.1.1条。巴西6.4.1.2条。阿根廷6.4.1.3条。拉丁美洲其他地区6.5条。中东和非洲6.5.1条。中东和非洲伙伴诊断市场:区域趋势分析6.5.1.1条。合同通用条款6.5.1.2条。南非6.5.1.3条。以色列6.5.1.4条。其他MEA7全球伙伴诊断市场竞争格局、市场份额分析和公司概况7.1条。市场份额分析7.2条。公司简介7.3条。罗氏制药公司7.3.1条。公司概况7.3.2条。财务亮点7.3.3条。产品组合7.3.4条。SWOT分析7.3.5条。关键战略和发展7.4条。雅培实验室7.4.1条。公司概况7.4.2条。财务亮点7.4.3条。产品组合7.4.4条。SWOT分析7.4.5条。关键战略和发展7.5条。赛默飞世尔科技7.5.1条。公司概况7.5.2条。财务亮点7.5.3条。产品组合7.5.4条。SWOT分析7.5.5条。关键战略和发展7.6条。安捷伦科技7.6.1条。公司概况7.6.2条。财务亮点7.6.3条。产品组合7.6.4条。SWOT分析7.6.5条。关键战略和发展7.7条。生命技术7.7.1条。公司概况7.7.2条。财务亮点7.7.3条。产品组合7.7.4条。SWOT分析7.7.5条。关键战略和发展7.8条。通用电气医疗7.8.1条。公司概况7.8.2条。财务亮点7.8.3条。产品组合7.8.4条。SWOT分析7.8.5条。关键战略和发展7.9条。阿根迪亚7.9.1条。公司概况7.9.2条。财务亮点7.9.3条。产品组合7.9.4条。SWOT分析7.9.5条。关键战略和发展7.10条。凯杰7.10.1条。公司概况7.10.2条。财务亮点7.10.3。产品组合7.10.4条。SWOT分析7.10.5条。关键战略和发展7.11条。基因组健康7.11.1条。公司概况7.11.2条。财务亮点7.11.3条。产品组合7.11.4条。SWOT分析7.11.5条。关键战略和发展7.12条。巨数遗传公司7.12.1条。公司概况7.12.2条。财务亮点7.12.3条。产品组合7.12.4条。SWOT分析7.12.5条。关键战略和发展7.13条。高级细胞诊断7.13.1条。公司概况7.13.2条。财务亮点7.13.3条。产品组合7.13.4条。SWOT分析7.13.5条。关键战略和发展7.14条。达纳赫7.14.1条。公司概况7.14.2条。财务亮点第十四条第三款。产品组合7.14.4条。SWOT分析7.14.5条。关键战略和发展7.15条。应用蛋白质组学7.15.1条。公司概况7.15.2条。财务亮点7.3.15条。产品组合7.15.4条。SWOT分析7.15.5条。关键战略和发展8假设和缩略语9研究方法10联系人ondemand视频报告代码57777单用户$3495.00多用户$5100.00公司用户$7200.00立即购买
Global Companion Diagnostics Market is estimated to be valued US$ XX.X million in 2019. The report on Companion Diagnostics Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global companion diagnostics market is segmented on the basis of type, application, and geography.
In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.
Global Companion Diagnostics Market
By type, the market is segmented into Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), and Next Generation Sequencing (NGS). By application, the market is divided into Hospitals, Pharmaceutical Companies, Laboratories, and Other.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen, Genomic Health, Myriad Genetics, Advanced Cell Diagnostics, Danaher, and Applied Proteomics.
Key Market Segments
Type
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Application
Hospitals
Pharmaceutical Companies
Laboratories
Other
Key Market Players included in the report:
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Companion Diagnostics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Companion Diagnostics Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Companion Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Companion Diagnostics Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Companion Diagnostics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Companion Diagnostics Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Companion Diagnostics sub-markets, depending on key regions (various vital states).
To analyze Companion Diagnostics Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Companion Diagnostics Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Companion Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Companion Diagnostics Market research study, the following years have been considered to estimate the market size:
ParticularScope
Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Historic Year2013 to 2018
Estimated Year2019
Forecast Year2020 to 2029
Companion Diagnostics Market
add_shopping_cartBuy Now get_appDownload Sample
keyboard_arrow_up
account_circleAbout Me
Report Code 57777
Single User $3,495.00
Multi User $5,100.00
Corporate Users $7,200.00
Buy Now
1. Companion Diagnostics Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope
2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players
3. Global Companion Diagnostics Market Overview
3.1. Companion Diagnostics Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges
3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER\’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy
4. Global Companion Diagnostics Market Value & Volume ((US$ Mn & \’000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Companion Diagnostics Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Polymerase Chain Reaction (PCR)
4.4. Immunohistochemistry (IHC)
4.5. In Situ Hybridization (ISH)
4.6. Next Generation Sequencing (NGS)
5. Global Companion Diagnostics Market Value & Volume ((US$ Mn & \’000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Companion Diagnostics Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Hospitals
5.4. Pharmaceutical Companies
5.5. Laboratories
5.6. Other
6. Global Companion Diagnostics Market Value & Volume ((US$ Mn & \’000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Companion Diagnostics Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico
6.2.1. Europe
6.2.1. Europe Companion Diagnostics Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Asia-Pacific Companion Diagnostics Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Latin America Companion Diagnostics Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Middle East and Africa Companion Diagnostics Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Companion Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Roche Holdings
7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments
7.4. Abbott Laboratories
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments
7.5. Thermo Fisher Scientific
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments
7.6. Agilent Technologies
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments
7.7. Life Technologies
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments
7.8. GE Healthcare
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments
7.9. Agendia
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments
7.10. Qiagen
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments
7.11. Genomic Health
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments
7.12. Myriad Genetics
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments
7.13. Advanced Cell Diagnostics
7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments
7.14. Danaher
7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments
7.15. Applied Proteomics
7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments
8. Assumptions and Acronyms
9. Research Methodology
10. Contact
ondemand_videoVideos
Report Code 57777
Single User $3,495.00
Multi User $5,100.00
Corporate Users $7,200.00
Buy Now